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Abstract: Binding of the HIV-1 envelope to its chemokine
coreceptors mediates two major biological events:
membrane fusion and signaling transduction. The fusion
process has been well studied, yet the role of chemokine
coreceptor signaling in viral infection has remained
elusive through the past decade. With the recent
demonstration of the signaling requirement for HIV latent
infection of resting CD4 T cells, the issue of coreceptor
signaling needs to be thoroughly revisited. It is likely that
virus-mediated signaling events may facilitate infection in
various immunologic settings in vivo where cellular
conditions need to be primed; in other words, HIV may
exploit the chemokine signaling network shared among
immune cells to gain access to downstream cellular
components, which can then serve as effective tools to
break cellular barriers. This virus-hijacked aberrant signal-
ing process may in turn facilitate pathogenesis. In this
review, we summarize past and present studies on HIV
coreceptor signaling. We also discuss possible roles of
coreceptor signaling in facilitating viral infection and
pathogenesis.
Introduction
I n f e c t i o nb yt h eh u m a ni m m u n o d eficiency virus (HIV) causes
severedepletion of the CD4 T cellpopulation, which eventually leads
to acquired immunodeficiency syndrome (AIDS). The selective
nature of the infection immediately prompted speculation and the
subsequent identification of the CD4 molecule as the main surface
receptor for HIV entry [1,2]. Nevertheless, it soon became apparent
that CD4 alone did not seem to be sufficient to permit entry [3,4]. A
hunt for the elusive coreceptors ensued. In 1996, Berger’s group first
identified a G-protein-coupled receptor designated ‘‘fusin’’ as the
elusive cofactor for HIV-1 entry [5]. ‘‘Fusin’’ was later renamed
CXCR4 after the realization that its natural ligand is the CXC
chemokine stromal cell derived factor 1 (SDF1) [6]. Before the
identification of ‘‘fusin’’, chemokines such as the CC chemokines
RANTES, MIP-1a, and MIP-1b had been reported to suppress
infection by the macrophage tropic (M-tropic) HIV-1 [7]. Thus, with
the identification of CXCR4, it took little time to confirm that CCR5,
the receptor for the aforementioned CC chemokines [8], was indeed
also a coreceptor for the entry of M-tropic HIV-1 [9,10,11,12,13].
Following the discoveries of CXCR4 and CCR5, several other G-
protein-coupled receptors have also been identified [14]. Neverthe-
less, the in vivo importance of these other coreceptors in viral
infection and pathogenesis is less studied than that of CXCR4 and
CCR5. This review focuses mainly on CXCR4 and CCR5 signaling.
The Signaling Diversity of the Chemokine
Coreceptors
The discovery of the HIV chemokine coreceptors opened up a
new avenue for AIDS research. The fact that both CXCR4 and
CCR5 are chemokine receptors raised interesting questions
regarding the role of chemokine receptor signaling in viral
infection and pathogenesis [5]. Early studies by Fauci’s group
demonstrated that the envelope from M-tropic but not T-tropic
viruses can trigger calcium flux that was inhibited by pertussis
toxin (PTX) or MIP-1b, which is suggestive of viral envelope-
induced signaling transduction through CCR5 [15]. Subsequently,
Davis et al. demonstrated that similar to SDF-1 and RANTES,
both the T-tropic and M-tropic envelopes can induce rapid
tyrosine phosphorylation of the protein tyrosine kinase Pyk2
through binding to CXCR4 or CCR5 [16]. Pyk2 phosphorylation
is frequently associated with G protein signaling and calcium flux.
These results provided early evidence that binding of the viral
envelope to its chemokine corecptors, both CXCR4 and CCR5,
not only mediates entry but also activates multiple intracellular
signaling cascades, a process mimicking chemokine signaling
through binding to their cognate receptors.
Chemokine receptor signaling is known to be diverse and is
coupled to distinct signaling pathways that mediate cell migration,
transcriptional activation, and cell growth and differentiation
(Figure 1). For example, SDF-1 binding to the G-protein-coupled
receptor CXCR4 activates heterotrimeric G-proteins (Ga and
Gbc). There are numerous classes of Ga (Gas,G ai,G aq,G a12/13),
and CXCR4 seems to be specifically coupled to Gai and Gaq.G aq
proteins activate phosphatidylinositol-specific phospholipases such
as phospholipase C-c (PLC-c), which hydrolyzes phosphatidylino-
sitol-4,5-biphosphate (PIP2) to generate inositol triphosphate (IP3)
and diacylglyerol (DAG). These events lead to calcium flux and
the activation of several PKC isoforms that have been shown to be
important for SDF-1-induced chemotaxis [17,18] (Figure 1A).
Another pathway activated from SDF-1 binding to CXCR4 is
through Gai protein activation, which inhibits adenylyl cyclases
that in turn lead to a reduction in cAMP levels as well as the
activation of phospholipases and phosphodiesterases. These events
result in the activation of the lipid kinase PI3K via Gai-coupled
Src-family kinases as well as PI3Kc through direct binding of Gbc
to the regulatory subunits of PI3Kc [19,20,21]. Protein kinase B
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(MEK-1) and extracellular signal-regulated kinase (ERK1/2) are
downstream of PI3K and function in cell survival and proliferation
[21,22,23]. PI3K also stimulates the tyrosine phosphorylation of
focal adhesion complex components such as proline-rich tyrosine
kinase (Pyk2) [16], paxillin, and Crk [21,24,25], all of which are
important for cell migration and cell adhesion. PI3K is also
upstream of the critical nuclear transcription activator NF-kB,
which regulates gene expression in response to inflammation and
activates HIV proviral gene expression [21,26] (Figure 1B).
SDF-1 binding to CXCR4 also results in GTP-bound Gbc,
which can stimulate guanine nucleotide exchange factors (GEFs)
such as TIAM1 and PREX1 specific for Rho family GTPases such
as Rac, Rho [27,28,29,30], Cdc42 [31], and Ral [32]. These
GTPases activate well-characterized downstream effector path-
ways, all of which modulate the cytoskeleton: Rac activates its
downstream effector p21-activated kinase (PAK), which then
activates LIM kinase (LIMK) [33], leading to the alteration of
cofilin activity, which regulates actin turnover. Cdc42 activation
promotes actin assembly through the Wiskott-Aldrich syndrome
family protein’s (WASP) activation of the actin nucleating protein
Arp2/3 [34]. RhoA activation can lead to microtubule rearrange-
ment through the Rho kinase (ROCK) activation of myosin light-
chain phosphatase (MLCP) (Figure 1C). Finally, SDF-1 has been
shown to activate perhaps some JAKs/STATs [35,36,37,38],
linking SDF-1-induced signaling to cytokine and growth factor–
driven pathways regulating cell proliferation and differentiation.
SDF-1 also activates Cbl/Cbl-b, which functions as an E3 ligase
regulating cell signaling through ubiquitination [39]. In summary,
most of these signaling molecules are components of the signaling
transduction pathways mediating chemotactic responses for
cytoskeleton rearrangement, cell polarization, and migration
[19,20,30], as well as transcriptional activation, cell survival, and
proliferation [21,22,40].
The Signaling Diversity of the HIV-1
Envelope–Coreceptor Interaction
Consistent with the signaling diversity of chemokine–coreceptor
interaction, binding of HIV-1 gp120 to CCR5 or CXCR4 has also
Figure 1. Chemokine receptor signaling pathways. SDF-1 binding to CXCR4 or RANTES/MIP-1a/MIP-1b binding to CCR5 activates G proteins
(Ga particularly Gai,G aq, and Gbc) and multiple downstream pathways. (A) Gaq activates phospholipases such as phospholipase C-c (PLC-c), which
hydrolyzes phosphatidylinositol-4,5-biphosphate (PIP2) to generate inositol triphosphate (IP3) and diacylglyerol (DAG), triggering calcium influx and
the activation of kinases such as protein kinase C (PKC). (B) Gai activates phospholipases, phosphodiesterases, and the lipid kinase PI3K via Src-family
kinases. Gbc also activates PI3Kc. PI3K activation stimulates downstream targets such as protein kinase B (PKB/Akt), NF-kB, mitogen/extracellular
signal-regulated kinase (MEK-1), and extracellular signal-regulated kinase (ERK1/2). PI3K also triggers the tyrosine phosphorylation of focal adhesion
complex components such as proline-rich tyrosine kinase (Pyk2), paxillin, Crk, and p130Cas. (C) GTP-bound Gbc stimulates guanine nucleotide
exchange factors (GEFs) such as TIAM1 and PREX1 specific for the Rho family GTPases (Rac/CDC42/RhoA). These GTPases activate pathways
regulating cytoskeleton: Rac activates p21-activated kinase (PAK), which then activates LIM kinase (LIMK), leading to cofilin phosporylation and actin
polymerization. CDC42 promotes actin assembly through the Wiskott-Aldrich Syndrome family protein (WASP) and actin-nucleating protein Arp2/3.
RhoA activates Rho kinase (ROCK) , leading to myosin light-chain (MLC) phosporylation and microtubule rearrangement. (D) SDF-1 may also trigger
Gai-independent activation of the JAK-STAT pathways.
doi:10.1371/journal.ppat.1000520.g001
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[41,42], Erk-1/2 [42], and CD4/CXCR4-dependent NFAT
(nuclear factor of activated T cells) nuclear translocation [43]
(Figure 2). Recently, gp120 was demonstrated to mediate
chemotaxis, actin cytoskeleton rearrangement [42,44], and the
activation of an actin depolymerization factor, cofilin, to increase
the cortical actin dynamics in resting CD4 T cells [44].
Given this array of targets that can be activated by gp120 in
vitro, one question is whether these signaling events are
physiological at the low gp120 dosages present in vivo. The
presumption based on plasma viral load is that the physiological
levels of gp120 are likely to be significantly lower than most of
those used in in vitro experiments [45]. However, the in vivo
concentrations of gp120, particularly the local gp120 concentra-
tions in tissues, are difficult to measure, and a large percentage of
the virus in the body is present in lymphoid tissues. Therefore, the
compartmentalized viral concentrations could be very high
regardless of the plasma viral loads [46]. Thus, the judgment of
whether or not an experimental gp120 dosage is physiological is
largely arbitrary at best. On the other hand, a recent experiment
suggested that a few HIV particles might be sufficient to trigger
signaling through CXCR4 [47].
In our recent studies of gp120 signaling in peripheral resting
CD4 T cells, we did notice dosage- and conformation-dependent
differences in gp120 signaling [44,48]. At high gp120 dosages,
gp120 acts more like SDF-1, triggering rapid cofilin phosphory-
lation and actin polymerization that was followed by cofilin
dephosphorylation and actin depolymerization [42,44]. At lower
dosages, gp120 was incapable of triggering such rapid changes, but
was able to mediate gradual cofilin dephosphorylation and actin
depolymerization [44,48]. These differences may play different
roles in various settings during the course of HIV infection.
Roles of HIV-1 Envelope–Coreceptor Signaling in
HIV Infection
The direct involvement of chemokine coreceptor signaling in
HIV infection has been speculated right from the identification of
the chemokine coreceptors [5]. Within a year of the initial
discovery, multiple groups started to test the requirement of
coreceptor signaling in HIV entry and subsequent replication
steps. Cocchi and colleagues were the first to demonstrate that
inhibition of coreceptor signaling through PTX neither inhibited
HIV-1 replication nor the ability of chemokines such as RANTES
to block HIV-1 entry into PM1 cells [49]. Similarly, Farzan et al.
further created three CCR5 mutants that abolished its signaling
ability to mobilize calcium but detected minimal effects on viral
entry and replication in Hela-CD4 cells [50]. These results were
corroborated by several other groups using cell lines transfected
with either CCR5- or CXCR4-signaling-defective mutants
[51,52,53,54,55]; the results largely suggested that the signaling
function of the chemokine coreceptors is an independent function
not required for viral entry or replication. Nevertheless, in the
following decade, a significant number of studies have been
published describing modulation of cellular functions by HIV
gp120 signaling, ranging from causing neurotoxicity to promoting
apoptosis. Therefore, the relevance of chemokine coreceptor
signaling to viral infection itself remained an open question. With
this significant issue unresolved, there were also sporadic findings
implying that chemokine coreceptor signaling might be important
for viral replication. For example, prestimulation of macrophages
or CD4 T cells with CC-chemokines was found to enhance HIV
replication [56,57]. Similar stimulation with viral gp120 can even
induce viral replication in cultures of resting CD4 T cells of
infected patients [58]. These positive effects of coreceptor signaling
were also reflected in facilitating HIV infection of non-natural
targets; the replication of some HIV-1 isolates in macaque cells
was blocked at a step after entry and reverse transcription but
prior to the nuclear import of the preintegration complex, and this
block could be relieved by the expression of human coreceptor
CCR5 or CXCR4 in macaque cells [59]. These results suggested a
possible involvement of coreceptor signaling in a post entry step.
In agreement with this hypothesis, Mori and colleagues demon-
strated that three to nine amino acid changes in the envelope of
SIVmac293 conferred upon the virus the ability to replicate 100–
1,000 times more efficiently in macrophages. Importantly, the
amino acid changes in the envelope did not enhance virus entry,
but rather affected some post entry steps [60]. Furthermore,
Arthos and colleagues [61] demonstrated that there was a direct
correlation between the capacity of viral envelopes to initiate
signaling and the ability of the same viruses to infect cells. They
also demonstrated that a signaling-deficient R5 HIV-1,
92MW959, entered macrophages but failed to replicate, and the
block was at a post entry step. In parallel, the density of CCR5 on
the cell surface also appeared to correlate with the capacity of the
coreceptor to transduce signals, and this capacity directly impacted
viral post entry processes such as reverse transcription and
integration [62]. Recently, Grainger and Lever [63] used a family
of new chemokine inhibitors to block chemokine receptor
Figure 2. Components of the chemokine coreceptor signaling
pathways activated by HIV-1 envelope. HIV-1 gp120 binding to
CXCR4 or CCR5 activates a number of signaling molecules common to
chemokine-mediated signaling pathways, including (A) PLC-c-depen-
dent calcium flux and NFAT nuclear translocation; (B) PI3K-dependent
activation of FAK, PyK2, AKT, and ERK1/2; (C) the downstream targets of
the Rho family GTPases such as LIMK1 and cofilin for actin
rearrangement.
doi:10.1371/journal.ppat.1000520.g002
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infected cells, these inhibitors inhibit HIV-1 infection without
blocking gp120/CCR5 interaction [63], and presumably, these
inhibitors also inhibited viral replication at steps post binding and
entry.
Despite growing evidence supporting a possible role for
coreceptor signaling, contradictory findings remained. Amara et
al. compared R5 HIV infection of CCR5 wild-type and signaling-
deficient T cells derived from CCR5D32 individuals [55]. In this
study, signaling-deficient CCR5 supported R5 HIV replication to
an extent similar to the wild-type CCR5, suggesting again that G
protein signaling through CCR5 plays no role in R5 HIV-1
replication. An important aspect of this study was the use of PHA
to activate primary T cells for transduction. In contrast, Lin et al.
used unstimulated primary T cells in a similar experiment and
showed that the signaling-deficient CCR5 T cells were impaired in
their support of HIV-1 infection [64]. Importantly, in order to
observe the inhibition, cells in this experiment had to be rested for
ten days after transduction before HIV-1 infection. These data are
consistent with an earlier observation that the B-oligomer of PTX,
although not directly inhibiting coreceptor signaling thourgh Gai,
diminishes the R5 virus-mediated receptor capping and reverse
transcription [65]. These inhibitory effects can only be observed in
primary monocyte-depleted PBMCs but not in transformed PM1
cells [65]. It is likely that much of the seemingly contradictory
observations in different studies may arise from the use of cells in
different activation states. When studies used activated T cells or
transformed cell lines, they largely observed that HIV-1 envelope–
coreceptor signaling was dispensable. Since a majority of T cells
and macrophages in vivo are in resting and noncycling states, it is
critical that the study of HIV-initiated signaling is investigated
using similar cells.
Recently, we examined the requirement for CXCR4 signaling
in HIV-1 latent infection of human resting CD4 T cells using an in
vitro system to mimic in vivo latent infection of resting T cells [44].
Using this system, we observed an absolute requirement of
CXCR4 signaling for HIV-1 latent infection of resting CD4 T
cells. This requirement was even maintained in resting T cells
exposed to certain cytokines such as IL-2 and IL-7, suggesting that
CXCR4 signaling could potentiate infectivity even in certain
cytokine-enriched microenvironments, such as lymphoid tissues.
We also identified the molecular mechanism of this signaling
requirement, and demonstrated that the static cortical actin in
noncycling, resting CD4 T cells represents a unique barrier for
viral post entry migration. To overcome this restriction, HIV-1
relies on viral envelope and the Gai-dependent signaling from the
chemokine coreceptor CXCR4 to activate a cellular actin-
depolymerizing factor, cofilin, to increase the cortical actin
dynamics (Figure 3). This unique requirement for coreceptor
signaling can only be observed in noncycling, resting CD4 T cells
because in transformed or activated T cells cofilin is constitutively
active to facilitate the cell cycle–driven actin remodeling that
renders CXCR4 signaling unnecessary [44].
With the identification of the molecular mechanism of CXCR4
signaling, the remaining issues are to confirm the requirement for
CCR5 signaling, and to determine the molecular basis for this
requirement. There appears to be a clear distinction in the
requirement for signaling between R5 and X4 viruses. For
example, the B-oligomer of PTX inhibits R5 virus at entry and
reverse transcription, but inhibits the X4 virus at multiple steps
post reverse transcription [65,66]. The R5 virus predominates at
the early time of HIV infection, largely infecting macrophages and
active memory CD4 T cells [67] in the gastrointestinal (GI) tract
and lymph nodes [68]. Both types of cells support productive viral
replication and do not have the restrictions usually seen in resting
CD4 T cells. It is unknown whether HIV-mediated cofilin
activation through CCR5 may also occur in active memory T
cells and macrophages, since cells that are actively cycling and
Figure 3. HIV-1 envelope-CXCR4 signaling triggers cofilin activation to promote cortical actin dynamics and HIV nuclear migration.
(A) HIV-1 envelope binding to CD4 and the chemokine coreceptor, CXCR4, triggers membrane fusion and signaling transduction. The initial viral
contact with CD4 and then CXCR4 may trigger rapid actin polymerization to facilitate CD4/CXCR4 cocapping for fusion and entry. Following fusion,
the viral preintegration complex (PIC) may be directly anchored onto F-actin to facilitate reverse transcription. Subsequent actin activity mediated by
cofilin activation through CXCR4 promotes viral nuclear migration. (B) Model of HIV PIC migration along the cortical actin filaments. It is possible that
cofilin activation increases actin treadmilling, which promotes the movement of the viral PIC across the cortical actin barrier, allowing PIC to gain
access to the perinuclear or nuclear region. The number is arbitrarily assigned to an actin monomer to demonstrate the actin movement during
treadmilling. (Figure 3 is modified from [44] with permission).
doi:10.1371/journal.ppat.1000520.g003
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leaving the cells naturally susceptible to HIV-1 infection. If
required, the CCR5 signaling might be involved in several early
processes: initial fusion and entry, uncoating, viral DNA synthesis,
or subsequent viral gene transcription. Chemokine receptor
signaling also triggers rapid actin polymerization [42,44], which
may be important for the cocapping of CD4 with CCR5 or
CXCR4 [69] and for the efficient synthesis of viral DNA [44,70].
This early actin polymerization appears to be involved in
assembling high concentrations of CD4 and CCR5 or CXCR4
at the plasma membrane, which facilitate gp120 binding and viral
entry (for a review, please see [71]). Nevertheless, it is unlikely that
this immediate actin activity is triggered through CCR5 or
CXCR4 exclusively. Rather, it may be mediated through the
initial gp120 contact with CD4 and then facilitated through
further gp120 contact with CCR5 or CXCR4 [72] (Figure 3).
Also, sufficient actin contact with the core following fusion is
probably critical for rapid uncoating, or a subsequent particle
conformational change that is necessary for optimal reverse
transcription. Indeed, excessive actin depolymerization inhibits
viral replication, and artificially increasing the cortical actin
density through small interfering RNA (siRNA)-mediated cofilin
knockdown enhances viral DNA synthesis [44]. In transformed
cell lines, the requirement for CCR5 signaling in viral replication
was not observed, likely because the cortical actin itself is dynamic
and minimally affected by inhibiting CCR5 signaling [44]. In
addition, the presence of CD4 signaling may also compensate
some of the early requirements for actin activity. Interestingly,
when the density of CCR5 was artificially increased on
transformed HOS-CD4 cells, a direct correlation between
CCR5 density and viral DNA synthesis was observed, and this
correlation was dependent on PTX-sensitive Gai signaling [62].
CCR5 signaling has also been known to trigger distinctive
signaling cascades that activate kinases and transcription factors
associated with cell activation [43,73,74]. For example, R5
envelopes can induce the expression of genes belonging to MAPK
signal transduction pathways and genes regulating the cell cycle
[74]. R5 envelopes can also activate NFATs and induce their
translocation into the nucleus [43]. Because the HIV long terminal
repeat (LTR) encodes NFAT recognition sites, NFAT activation
likely enhances viral transcription directly from the LTR
promoter, especially at early time points when cellular conditions
are limiting. For example, the microenvironment in the GI tract
where the R5 viruses infect active memory T cells is filled with
inhibitory cytokines such as TGF-b [75], which can reorganize
cytoskeletal structure [76] and inhibit the activation of major
transcription factors such as NFkB [77]. The contribution of
CCR5 signaling to viral transcription could probably be observed
in suboptimally activated cells, but may not be seen in highly
active transformed cell lines.
Possible Roles of HIV-1 Envelope–Receptor
Signaling in Viral Pathogenesis
It has long been suggested that HIV-1 envelope plays a central
role in HIV-mediated CD4 T cell depletion and pathogenesis.
Prior to the identification of the chemokine coreceptors, gp120
was proposed to directly trigger activation-dependent T cell
apoptosis through its binding to surface CD4 [78]. Later, when the
chemokine coreceptors were discovered, gp120 binding to CCR5
or CXCR4 was also proposed to trigger the apoptosis of CD4
cells, CD8 T cells [79,80], and neurons [81]. There was
considerable complexity and discrepancy regarding possible
mechanisms of gp120-mediated apoptosis in T cells, in terms of
possible involvements of Gai-dependent pathways and caspases
[80,82], as well as the involvement of autophagy [83]. Envelope-
primed apoptosis has been implicated as directly contributing to
the depletion of either infected or uninfected CD4 T cells during
disease progression [78,84,85]. Nevertheless, latently infected
resting T cells were frequently detected persisting in patients
[86], and the half life of these cells can be as long as 3 to 4 years
[87]. These in vivo findings suggested that although gp120 can
trigger T cell apoptosis in certain circumstances, there must be
mechanisms that may prevent this process from occurring during
the initial virus–cell engagement [88].
HIV envelope–chemokine receptor signaling has been shown to
mediate chemotaxis in both CD4 and CD8 T cells
[15,42,44,89,90], a property directly related to the role of
chemokine receptor signaling. The viral envelope has also been
suggested to do the opposite by repelling T cells [89], a process
resembling chemofugetaxis, in which high concentrations of
chemokines such as SDF-1 drive away T cells [91]. It has been
proposed that this capacity of gp120 repels antigen-specific
cytotoxic T lymphocytes from viral infection sites to evade
immune effector mechanisms [89]. Similar functions of gp120 in
modulating the immune system have also been suggested. For
example, persistent gp120 stimulation induces CXCR4-dependent
T cell anergy [92], as well as CCR5- and CXCR4-dependent
macrophage activation and the secretion of proinflammatory
cytokines [93]. Many of these gp120-induced phenotypes resemble
the pathogenic features of HIV-induced T cell dysfunction and
chronic immune activation [92,94,95,96,97]. However, the
molecular targets and signaling mechanisms directly responsible
for these phenotypes remain largely uncharacterized. Recently, we
identified cofilin as one of the primary downstream targets of
gp120–CXCR4 signaling in human resting CD4 T cells [44]. We
also found that in the resting CD4 T cells of infected patients,
cofilin activity is aberrantly upregulated [48]. HIV-mediated
cofilin activation likely results from a bystander effect since a
majority of resting CD4 T cells in the peripheral blood of infected
patients contain no virus (0.2–16.4 cells latently infected with HIV
per 10
6 resting CD4 T cells [98]). Although not directly infected,
these residual CD4 T cells in patients are also known to carry
numerous functional abnormalities such as loss of T helper
function [94], anergy [92,95], increased T cell proliferation [99],
and abnormal T cell homing and migration [89,100].
In the human immune system, cofilin is involved in two
hallmark activities of T cells, namely chemotaxis and T cell
activation [101]. In chemotaxis, cofilin is the driving force for
promoting the cortical actin dynamics central to cell migration
[33]. In antigen-specific T cell activation, cofilin is activated
through CD2/CD28 co-stimulation, and plays a critical role in
actin reorganization and the formation of the immunological
synapse that is required for sustaining T cell activation [102]. It is
possible that cofilin dysregulation could result in CD4 T cell
abnormities that may contribute to T cell depletion and immune
deficiencies. Severe effects of altered actin dynamics on the human
immune system have been well documented. For instance, a
genetic defect of WASP that affects actin dynamics causes
immunodeficiency [103]. HIV-mediated aberrant activation of
cofilin strikingly resembles the activation of cofilin detected in
migratory T lymphoma cells [104]. This resemblance may
indicate a similar abnormal migratory behavior that could result
in the eventual destruction of peripheral CD4 T cells in lymph
nodes or tissues of HIV patients.
The utilization of different chemokine coreceptors, either
CCR5 or CXCR4, for entry largely differentiates HIV into two
distinctive phenotypes with either M- or T-tropism. The high
PLoS Pathogens | www.plospathogens.org 5 December 2009 | Volume 5 | Issue 12 | e1000520pathogenic potential of the late emerging T-tropic viruses in
causing rapid CD4 depletion is clearly a demonstration of the
pathogenic significance of the CXCR4-engaging viruses
[105,106,107]. Nevertheless, a remaining question for the
importance of CXCR4 signaling in HIV pathogenesis is the lack
of X4 viruses in some patients. There are only approximately 50%
patients who experience the conversion from R5 to X4 viruses at
later stages of disease. It is possible that in these patients, a
complete viral switch from M- to T-tropism may never occur, but
constant viral mutation may generate intermediate viruses that can
engage and signal through CXCR4. It has been known that one or
two amino acid changes in the V3 loop of the viral envelope may
confer CXCR4 binding [108], although successful fusion and
entry often require more than two mutations or mutations even
outside of the V3 loop [109]. It is also possible that these
hypothetical X4-signaling viruses may trigger signaling transduc-
tion and cause CD4 T cell dysfunction without actually replicating
in them (for further reading on this hypothesis, please see [110]).
In comparison with the highly pathogenic T-tropic viruses, these
M-tropic, X4-signaling viruses may cause slower CD4 depletion
and disease progression.
Conclusions and Perspectives
Understanding HIV envelope–coreceptor interaction holds the
key to unlocking the mystery of HIV-mediated CD4 depletion and
pathogenesis. The signaling capacity of the viral envelope, along
with its pathogenic potential, has been a subject of great interest
and intense investigation. Yet, the critical role of the coreceptor
signaling in HIV disease had not been clearly defined. This lack of
appreciation has been largely attributed to the complexity of the
chemokine signaling network itself, as well as the complication of
many in vitro systems used, in which cellular states are derailed
from the genuine signaling circuitries of natural viral targets in the
body. Given these complexities, a critical function of the
coreceptor signaling in promoting viral infection has only recently
been demonstrated in the latent infection of human resting CD4 T
cells. The deciphering of the molecular mechanisms involved starts
to offer exciting fresh perspectives and opens a new avenue for
examining HIV pathogenesis. However, a great deal is yet to be
tested regarding the in vivo importance of coreceptor signaling in
mediating CD4 T cell dysfunction and pathogenesis.
Gene Accession Numbers
Human CXCR4 – Entrez Gene ID # 7852; Human CCR5 –
Entrez Gene ID # 1234; Human non-muscle Cofilin 1 – Entrez
Gene ID # 1072.
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